Skip to main content

Kezar Life Sciences, Inc.

KZRDelisted May 11, 2026
Industry
Pharmaceutical Preparations
SEC CIK
0001645666

Kezar Life Sciences, Inc. was delisted on May 11, 2026; its insiders filed their last Form 4 on May 11, 2026; 43 institutions reported holding it in 13F filings for Q1 2026, worth $32.8M in total; no superinvestor held it.

13F holders, Q2 2022

Institutional positions in Kezar Life Sciences, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
127
+6 vs. Q1 2022
Shares held
54.9M
+10.9M (+24.6%) vs. Q1 2022
Total value
$454.0M
−$277.9M (−38.0%) vs. Q1 2022
New holders
30
51 more added
Sold out
24
34 more reduced

2 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q1 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting KZR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2022: 127 institutions
Q1 2021: 83 institutionsQ2 2021: 75 institutionsQ3 2021: 77 institutionsQ4 2021: 107 institutionsQ1 2022: 123 institutionsQ2 2022: 127 institutionsQ3 2022: 132 institutionsQ4 2022: 123 institutionsQ1 2023: 137 institutionsQ2 2023: 104 institutionsQ3 2023: 82 institutionsQ4 2023: 81 institutionsQ1 2024: 85 institutionsQ2 2024: 81 institutionsQ3 2024: 60 institutionsQ4 2024: 43 institutionsQ1 2025: 41 institutionsQ2 2025: 40 institutionsQ3 2025: 39 institutionsQ4 2025: 43 institutionsQ1 2026: 43 institutionsQ2 2026: 0 institutions
Value heldQ2 2022: $454.0M
Q1 2021: $158.0MQ2 2021: $150.1MQ3 2021: $242.7MQ4 2021: $674.1MQ1 2022: $734.1MQ2 2022: $454.0MQ3 2022: $495.5MQ4 2022: $404.2MQ1 2023: $188.1MQ2 2023: $139.4MQ3 2023: $66.0MQ4 2023: $46.8MQ1 2024: $40.3MQ2 2024: $23.6MQ3 2024: $31.6MQ4 2024: $28.2MQ1 2025: $21.1MQ2 2025: $20.5MQ3 2025: $16.5MQ4 2025: $28.1MQ1 2026: $32.8MQ2 2026: $0
Institutions holding KZR and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 202643$32.8M
Q4 202543$28.1M
Q3 202539$16.5M
Q2 202540$20.5M
Q1 202541$21.1M
Q4 202443$28.2M
Q3 202460$31.6M
Q2 202481$23.6M
Q1 202485$40.3M
Q4 202381$46.8M
Q3 202382$66.0M
Q2 2023104$139.4M
Q1 2023137$188.1M
Q4 2022123$404.2M
Q3 2022132$495.5M
Q2 2022127$454.0M
Q1 2022123$734.1M
Q4 2021107$674.1M
Q3 202177$242.7M
Q2 202175$150.1M
Q1 202183$158.0M

Institutions, Q2 2022

Shares, value and share of portfolio for each institution holding Kezar Life Sciences, Inc.; share changes are against Q1 2022.

Institutions holding KZR in Q2 2022
InstitutionSharesValue% of portfolioChange in sharesAction
Two Sigma Advisers, LP654,800$5.42M0.02%+155,300+31.1%Added
Palo Alto Investors LP656,200$5.43M0.47%00.0%Unchanged
Goldman Sachs Group Inc682,572$5.64M0.00%+423,377+163.3%Added
State Street Corp735,090$6.08M0.00%−1,507,464−67.2%Reduced
Geode Capital Management, LLC776,114$6.42M0.00%+101,886+15.1%Added
Qiming U.S. Ventures Management, LLC828,711$6.85M9.51%00.0%Unchanged
Northern Trust Corp926,519$7.66M0.00%+489,086+111.8%Added
Logos Global Management LP950,000$7.86M1.44%−664,021−41.1%Reduced
JPMorgan Chase & Co1,101,536$9.11M0.00%+1,037,748+1,626.9%Added
Cormorant Asset Management, LP1,200,000$9.92M0.77%+1,200,000New
HealthCor Management, L.P.1,209,880$10.0M1.03%+1,209,880New
Prosight Management, LP1,262,691$10.4M8.46%+962,691+320.9%Added
Hood River Capital Management LLC1,361,120$11.3M0.45%+1,361,120New
Franklin Resources Inc1,365,323$11.3M0.01%−1,120,747−45.1%Reduced
Ikarian Capital, LLC1,408,116$11.6M4.83%+325,000+30.0%Added
Deerfield Management Company, L.P. (Series C)1,419,000$11.7M0.25%+1,419,000New
OrbiMed Advisors LLC1,419,900$11.7M0.23%+1,419,900New
Point72 Asset Management, L.P.1,608,400$13.3M0.06%−656,887−29.0%Reduced
CHI Advisors LLC1,840,793$15.2M5.82%+1,526,181+485.1%Added
Marshall Wace, LLP1,908,515$15.8M0.04%+1,453,020+319.0%Added
Vanguard Group Inc2,437,187$20.2M0.00%+209,103+9.4%Added
Millennium Management LLC2,748,946$22.7M0.03%+1,826,884+198.1%Added
Victory Capital Management Inc2,770,098$22.9M0.03%+1,017,391+58.0%Added
Bellevue Group AG3,035,000$25.1M0.35%−1,633,148−35.0%Reduced
BlackRock Inc.3,579,790$29.6M0.00%+682,716+23.6%Added
Avidity Partners Management LP4,050,000$33.5M0.77%+532,000+15.1%Added
Suvretta Capital Management, LLC4,412,300$36.5M1.39%+3,002,344+212.9%Added
Holocene Advisors, LP0$00.00%−1,573,054−100.0%Sold out
Norges Bank0$00.00%−491,500−100.0%Sold out
EAM Investors, LLC0$00.00%−293,559−100.0%Sold out
Fred Alger Management, LLC0$00.00%−170,703−100.0%Sold out
Slow Capital, Inc.0$00.00%−150,663−100.0%Sold out
EAM Global Investors LLC0$00.00%−146,426−100.0%Sold out
Rafferty Asset Management, LLC0$00.00%−137,350−100.0%Sold out
D. E. Shaw & Co., Inc.0$00.00%−95,021−100.0%Sold out
Endurant Capital Management LP0$00.00%−59,474−100.0%Sold out
Federated Hermes, Inc.0$00.00%−48,661−100.0%Sold out
Ci Investments Inc.0$00.00%−31,729−100.0%Sold out
Blueshift Asset Management, LLC0$00.00%−25,368−100.0%Sold out
Virtu Financial LLC0$00.00%−20,012−100.0%Sold out
Belvedere Trading LLC0$00.00%−17,269−100.0%Sold out
Nwam LLC0$00.00%−12,592−100.0%Sold out
ProShare Advisors LLC0$00.00%−12,186−100.0%Sold out
Fox Run Management, L.L.C.0$00.00%−10,828−100.0%Sold out
Qube Research & Technologies Ltd0$00.00%−10,053−100.0%Sold out
Sio Capital Management, LLC0$00.00%−9,168−100.0%Sold out
Dorsey Wright & Associates0$00.00%−3,601−100.0%Sold out
State of Wyoming0$00.00%−2,200−100.0%Sold out
High Net Worth Advisory Group LLC0$00.00%−200−100.0%Sold out
Glassman Wealth Services0$00.00%−60−100.0%Sold out
CWM, LLC0$00.00%−26−100.0%Sold out
Parametric Portfolio Associates LLC––––Not filed
Amalgamated Financial Corp.––––Not filed